Edgestream Partners L.P. Takes Position in The Cigna Group (NYSE:CI)

Edgestream Partners L.P. purchased a new stake in shares of The Cigna Group (NYSE:CI) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 4,855 shares of the health services provider’s stock, valued at approximately $1,763,000.

A number of other institutional investors also recently bought and sold shares of the company. Seizert Capital Partners LLC grew its position in shares of The Cigna Group by 195.8% during the fourth quarter. Seizert Capital Partners LLC now owns 32,150 shares of the health services provider’s stock worth $9,627,000 after purchasing an additional 21,280 shares in the last quarter. Roman Butler Fullerton & Co. increased its holdings in shares of The Cigna Group by 61.4% in the 4th quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock valued at $2,772,000 after acquiring an additional 3,539 shares during the period. TFO Wealth Partners LLC increased its holdings in shares of The Cigna Group by 98,980.0% in the 4th quarter. TFO Wealth Partners LLC now owns 4,954 shares of the health services provider’s stock valued at $1,497,000 after acquiring an additional 4,949 shares during the period. Ellsworth Advisors LLC purchased a new position in shares of The Cigna Group in the 4th quarter valued at $4,377,000. Finally, Sapient Capital LLC purchased a new position in The Cigna Group during the 4th quarter worth $2,811,000. Institutional investors own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

CI has been the subject of a number of research reports. Baird R W raised The Cigna Group to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 price target on shares of The Cigna Group in a research note on Wednesday, July 10th. Piper Sandler started coverage on The Cigna Group in a research note on Wednesday, June 26th. They issued an “overweight” rating and a $400.00 price target for the company. Oppenheimer boosted their price objective on The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a research note on Friday, May 3rd. Finally, StockNews.com lowered The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, The Cigna Group currently has an average rating of “Buy” and an average price target of $376.20.

The Cigna Group Stock Performance

Shares of CI traded down $0.05 during midday trading on Monday, reaching $335.79. 751,924 shares of the stock were exchanged, compared to its average volume of 1,583,474. The business’s 50-day moving average price is $335.33 and its 200 day moving average price is $336.84. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.71 and a quick ratio of 0.71. The Cigna Group has a twelve month low of $253.95 and a twelve month high of $365.71. The company has a market capitalization of $95.39 billion, a price-to-earnings ratio of 27.57, a PEG ratio of 1.02 and a beta of 0.52.

The Cigna Group (NYSE:CI) last posted its earnings results on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, topping analysts’ consensus estimates of $6.17 by $0.30. The business had revenue of $57.25 billion for the quarter, compared to analysts’ expectations of $56.59 billion. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The business’s revenue was up 23.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.41 earnings per share. On average, sell-side analysts expect that The Cigna Group will post 28.47 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 20th. Investors of record on Tuesday, June 4th were given a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.67%. The ex-dividend date of this dividend was Tuesday, June 4th. The Cigna Group’s dividend payout ratio (DPR) is presently 45.98%.

Insider Activity at The Cigna Group

In related news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the business’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $348.71, for a total value of $2,073,429.66. Following the transaction, the senior vice president now owns 2,595 shares in the company, valued at approximately $904,902.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of The Cigna Group stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $348.71, for a total value of $2,073,429.66. Following the sale, the senior vice president now owns 2,595 shares of the company’s stock, valued at approximately $904,902.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Noelle K. Eder sold 10,700 shares of The Cigna Group stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $348.47, for a total value of $3,728,629.00. Following the completion of the sale, the insider now directly owns 15,824 shares in the company, valued at approximately $5,514,189.28. The disclosure for this sale can be found here. Insiders have sold 22,988 shares of company stock worth $7,975,726 in the last quarter. Company insiders own 0.60% of the company’s stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.